Results 151 to 160 of about 10,024 (235)

The Therapeutic Potential for Steroid Treatment Strategies in the Treatment of Murine Venezuelan Equine Encephalitis Virus (VEEV) Infection. [PDF]

Viruses
Phelps AL, Hooton PL, Eastaugh L, Jenner D, Lever MS, Laws TR.   +5 more
europepmc   +1 more source

Divergent sustainability profiles of molnupiravir synthesis routes are governed by solvent use and process design. [PDF]

Proc Natl Acad Sci U S A
Chen Z, Lian JZ, Huang H, Zhu H, Kanye LT, Chen M, Zhang Z, Liu B, Zhang J, Ahmed A, Barbarossa V, Cucurachi S, Dong B.   +12 more
europepmc   +1 more source

Antiviral activities of multiple antivirals against highly pathogenic avian influenza A H5N1 <i>in vitro</i> and in mice. [PDF]

Emerg Microbes Infect
Liu D, Fan Y, Leung KY, Zhang R, Lam HY, Xie X, Chen H, Chan KH, Hung IF.   +8 more
europepmc   +1 more source

Molnupiravir, une affaire franco-européenne

Revue Francophone des Laboratoires, 2021
openaire   +2 more sources

<i>In vivo</i> pharmacokinetic evaluation of molnupiravir in patients with severe chronic kidney disease. [PDF]

Front Pharmacol
Wang Y, Chen Q, Liu X, Zhang L, Chen M, Wang S, Yang M, Fan G, Fan Q.   +8 more
europepmc   +1 more source

Persistent SARS-CoV-2 Infection in an Immunocompromised Host Treated Successfully With the Japanese Herbal Medicine, Mao-to: A Case Report. [PDF]

Am J Case Rep
Yamada T, Sonoda S, Otsuka M, Shirai T, Tateishi T, Furusawa H, Miyazaki Y.   +6 more
europepmc   +1 more source

Successful Treatment of Persistent and Relapsing COVID-19 with Ensitrelvir in a Patient with Obinutuzumab-Induced Long-Term B-Cell Depletion: A Case Report. [PDF]

Reports (MDPI)
Haino Y, Kenzaka T, Hayashi T, Yakushijin K.   +3 more
europepmc   +1 more source

Developing Synthetic Full-Length SARS-CoV-2 cDNAs and Reporter Viruses for High-Throughput Antiviral Drug Screening. [PDF]

Viruses
Rohamare M, Kaushik N, Khan JQ, Balouchi M, Lopez-Orozco J, Kozak R, Hobman TC, Falzarano D, Kumar A, Wilson JA.   +9 more
europepmc   +1 more source

Treatment Duration of Each Anti-COVID-19 Agent Used in a Tertiary Hospital in Japan. [PDF]

Cureus
Seki M, Enami K.
europepmc   +1 more source